Key result
US CHD mortality drops ~75% from 1968 to 2019.
Why the study?
Congenital heart disease remains the leading cause of infant mortality due to birth defects in the United States, prompting an analysis of long-term mortality trends across demographic groups.
Observational (n=234,658)
Effect estimate: AAPC -2.7% (95% CI -2.9 to -2.5)
Absolute Event Rate: 0.8% vs 3.2%
Congenital heart disease mortality in the US has declined significantly over the past five decades, but progress has plateaued since 2009, with persistent disparities by race and sex.
Sustained US CHD mortality decline supports ongoing surveillance; leaves open drivers of post-2009 plateau and disparities.
Purpose: Congenital heart disease (CHD) remains the leading cause of infant mortality due to birth defects in the United States. We analyzed long-term CHD mortality trends across age, sex, and racial groups from 1968 to 2022. Methods: We extracted CHD mortality data from the CDC WONDER database (1968-2022), using ICD-8/9/10 codes. Age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) were calculated per 100,000 population. Joinpoint regression was used to assess temporal trends in mortality, reporting annual percentage changes (APCs) and average APCs (AAPCs) with 95 % confidence intervals (CIs). Results: From 1968 to 2019, 234,658 CHD-related deaths were recorded. Overall AAMR declined from 3.2 (1968) to 0.8 (2019) per 100,000 (AAPC: -2.7 %; 95 % CI: -2.9 to -2.5). Males consistently had higher AAMRs than females. Racial disparities persisted, with slower declines among Black or African American individuals. Infants under 1 year accounted for 56.0 % of CHD deaths and showed the steepest mortality decline (AAPC: -3.2 %). Mortality rates plateaued in recent years. Conclusions: CHD mortality in the U.S. has declined markedly over the past five decades, though progress has slowed since 2009. Persistent disparities by race and sex emphasize the need for equitable access to specialized CHD care and ongoing public health efforts.
No takes yet. Share an insight, caveat, or question.
Imran et al. (2025) conducted an observational in Congenital heart disease (CHD) mortality (n=234,658). Time period (1968-2019) vs. Historical rates (1968) was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 population (AAPC -2.7%, 95% CI -2.9 to -2.5). Overall age-adjusted congenital heart disease mortality in the United States declined from 3.2 per 100,000 in 1968 to 0.8 per 100,000 in 2019, with an average annual percentage change of -2.7%.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: